Women's Health Research Center
Welcome,         Profile    Billing    Logout  
 10 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Stephanie J
NCT04572815: Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Recruiting
2
116
US
Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Ustekinumab, CNTO 1275, CNTO1275, Immunoglobulin G1, Anti-(Human Interleukin-12 Subunit beta (IL-12B, CLMF p40, NKSF2)) (Human Monoclonal CNTO 1275 gamma1-chain), Disulfide with Human Monoclonal CNTO 1275 kappa-chain, Dimer, Stelara
Fred Hutchinson Cancer Center
Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm
03/26
09/27
NCT04198922: Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Recruiting
2
50
US
Acalabrutinib, 1420477-60-6, ACP-196, Benzamide, Bruton Tyrosine Kinase Inhibitor ACP-196, Questionnaire Administration
Fred Hutchinson Cancer Center, AstraZeneca
Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm
12/25
01/27
NCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Recruiting
2
82
US
Belumosudil, KD 025, KD-025, KD025, Rho-associated Coiled-coil Kinase 2 Inhibitor KD025, ROCK-II Inhibitor KD025, ROCK2 Inhibitor KD025, SLx 2119, SLx-2119, SLx2119, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Electronic Health Record Review, Placebo Administration
Fred Hutchinson Cancer Center, Sanofi
Chronic Graft Versus Host Disease
05/27
12/27
NCT04111497: Glasdegib for Chronic Graft-Versus-Host Disease

Terminated
1/2
15
US
Glasdegib, 1095173-27-5, PF 04449913, PF-04449913, PF04449913
Fred Hutchinson Cancer Center, Pfizer
Chronic Graft Versus Host Disease, Fasciitis
08/23
08/23
NCT00637689: Improving Outcomes Assessment in Chronic GVHD

Active, not recruiting
N/A
601
US
Fred Hutchinson Cancer Center, University of Minnesota, Stanford University, Dana-Farber Cancer Institute, Vanderbilt University, Medical College of Wisconsin, Washington University School of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Chronic Graft Versus Host Disease
05/17
02/26
NCT01902576: Chronic GVHD Response Measures Validation

Active, not recruiting
N/A
383
US
Fred Hutchinson Cancer Center
Graft vs Host Disease
09/19
02/26
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage

Terminated
N/A
86
Europe
A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
University College, London, University of Oxford, The Stroke Association, United Kingdom
Intracerebral Hemorrhage
05/22
04/23
NCT06202677: Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms

Active, not recruiting
N/A
225
RoW
Self-guided program on obsessive compulsive disorder, Self-guided program on cooperation
National University of Singapore, Intellect Pte. Ltd.
Obsessive-Compulsive Disorder
03/24
07/24
BMT CTN 1702, NCT03904134: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation

Active, not recruiting
N/A
1753
US
Donor Search Prognosis Score
Center for International Blood and Marrow Transplant Research, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program, Medical College of Wisconsin
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Acquired Aplastic Anemia, Sickle Cell Disease
06/24
03/25
CATCH, NCT04188912: Close Assessment and Testing for Chronic Graft Versus Host Disease, Study

Active, not recruiting
N/A
273
US
Biospecimen Collection, Optical Coherence Tomography, OCT, Spirometry, Survey Administration, Digital Photography, Quality-of-Life Assessment, Quality of Life Assessment, Medical Chart Review, Chart Review
Fred Hutchinson Cancer Center, National Cancer Institute (NCI), National Institutes of Health (NIH)
Hematopoietic and Lymphoid Cell Neoplasm
10/25
10/25
NCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Recruiting
N/A
200
Canada, US
Biospecimen Collection, Medical Chart Review, Chart Review, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Chronic Graft Versus Host Disease
08/26
08/26
Eder, Scott
No trials found

Download Options